• eTheRNA
  • Empowering the human immune system with targeted and safe mRNA therapies to help patients fight cancer and infectious diseases

Management team

eTheRNA immunotherapies is managed by a small and close-knit team of committed biotech professionals. On the one hand this team includes the key scientists who have developed the mRNA-based immunotherapy platform at the VUB Brussels University.

Mid 2015, this founding team was strengthened by the entry of a number of pharma entrepreneurs with a strong track record in advancing research projects towards marketable medicines as well as in securing financial resources. The expanded management team is fully committed to bring eTheRNA’s mRNA-based TriMix technology to the next level.